Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 10 | 2022 | 808 | 1.680 |
Why?
|
| Biomarkers, Tumor | 8 | 2022 | 323 | 1.460 |
Why?
|
| Glypicans | 3 | 2009 | 3 | 0.910 |
Why?
|
| Immunohistochemistry | 6 | 2016 | 663 | 0.760 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2022 | 118 | 0.700 |
Why?
|
| Liver Neoplasms | 3 | 2022 | 191 | 0.670 |
Why?
|
| Keratins | 1 | 2016 | 25 | 0.520 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2014 | 26 | 0.520 |
Why?
|
| Curettage | 2 | 2020 | 5 | 0.490 |
Why?
|
| Antibodies | 1 | 2016 | 151 | 0.490 |
Why?
|
| Uterine Diseases | 1 | 2014 | 6 | 0.450 |
Why?
|
| Endometrium | 1 | 2014 | 15 | 0.450 |
Why?
|
| Specimen Handling | 1 | 2014 | 50 | 0.430 |
Why?
|
| Neoplasms, Basal Cell | 1 | 2014 | 2 | 0.430 |
Why?
|
| Biopsy | 1 | 2014 | 228 | 0.420 |
Why?
|
| Mastectomy, Segmental | 2 | 2022 | 19 | 0.370 |
Why?
|
| Female | 18 | 2022 | 20392 | 0.320 |
Why?
|
| Precancerous Conditions | 1 | 2007 | 41 | 0.270 |
Why?
|
| Melanoma | 1 | 2009 | 175 | 0.270 |
Why?
|
| Humans | 22 | 2022 | 40217 | 0.260 |
Why?
|
| Urinary Bladder Diseases | 1 | 2004 | 3 | 0.230 |
Why?
|
| Mullerian Ducts | 1 | 2004 | 3 | 0.230 |
Why?
|
| Urinary Bladder | 1 | 2004 | 22 | 0.230 |
Why?
|
| Aged, 80 and over | 6 | 2018 | 3136 | 0.210 |
Why?
|
| Mammography | 2 | 2022 | 204 | 0.200 |
Why?
|
| Biopsy, Fine-Needle | 3 | 2022 | 36 | 0.190 |
Why?
|
| Microscopy | 1 | 2022 | 73 | 0.180 |
Why?
|
| Adenocarcinoma | 2 | 2020 | 198 | 0.170 |
Why?
|
| Colposcopy | 1 | 2020 | 12 | 0.170 |
Why?
|
| Cervix Uteri | 1 | 2020 | 41 | 0.170 |
Why?
|
| Hepatitis C | 1 | 2022 | 121 | 0.160 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2020 | 89 | 0.160 |
Why?
|
| Middle Aged | 7 | 2020 | 10090 | 0.150 |
Why?
|
| Aged | 6 | 2018 | 8182 | 0.150 |
Why?
|
| Receptors, Somatomedin | 1 | 2018 | 8 | 0.140 |
Why?
|
| Carcinoma, Lobular | 1 | 2018 | 11 | 0.140 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2018 | 53 | 0.140 |
Why?
|
| MicroRNAs | 1 | 2022 | 535 | 0.130 |
Why?
|
| Cytodiagnosis | 2 | 2022 | 25 | 0.120 |
Why?
|
| Observer Variation | 1 | 2014 | 107 | 0.110 |
Why?
|
| Neoplasms, Fibroepithelial | 1 | 2014 | 3 | 0.110 |
Why?
|
| Adult | 5 | 2020 | 10255 | 0.110 |
Why?
|
| Prognosis | 2 | 2014 | 921 | 0.110 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2014 | 27 | 0.110 |
Why?
|
| Sensitivity and Specificity | 2 | 2020 | 698 | 0.100 |
Why?
|
| Coloring Agents | 1 | 2012 | 42 | 0.100 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2012 | 12 | 0.090 |
Why?
|
| Molecular Imaging | 1 | 2012 | 37 | 0.090 |
Why?
|
| Neuroendocrine Tumors | 1 | 2012 | 12 | 0.090 |
Why?
|
| Tonsillar Neoplasms | 1 | 2011 | 1 | 0.090 |
Why?
|
| Carcinoma | 1 | 2012 | 94 | 0.090 |
Why?
|
| Tomography, Optical Coherence | 1 | 2012 | 92 | 0.090 |
Why?
|
| Age Factors | 1 | 2014 | 1069 | 0.090 |
Why?
|
| Papillomaviridae | 1 | 2011 | 38 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2011 | 44 | 0.090 |
Why?
|
| Mesothelioma, Cystic | 1 | 2011 | 1 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 532 | 0.090 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2011 | 21 | 0.090 |
Why?
|
| In Situ Hybridization | 1 | 2011 | 193 | 0.090 |
Why?
|
| Peritoneal Neoplasms | 1 | 2011 | 18 | 0.090 |
Why?
|
| Pancreatic Neoplasms | 1 | 2012 | 177 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 419 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2011 | 168 | 0.080 |
Why?
|
| Pilot Projects | 2 | 2012 | 680 | 0.080 |
Why?
|
| Testicular Neoplasms | 1 | 2009 | 16 | 0.080 |
Why?
|
| Male | 4 | 2011 | 18271 | 0.070 |
Why?
|
| Ovarian Neoplasms | 1 | 2009 | 85 | 0.070 |
Why?
|
| Immunoenzyme Techniques | 1 | 2007 | 88 | 0.070 |
Why?
|
| Lung Neoplasms | 1 | 2009 | 252 | 0.060 |
Why?
|
| Radar | 1 | 2022 | 4 | 0.050 |
Why?
|
| Wireless Technology | 1 | 2022 | 17 | 0.050 |
Why?
|
| Egypt | 1 | 2022 | 5 | 0.050 |
Why?
|
| Cytological Techniques | 1 | 2022 | 17 | 0.050 |
Why?
|
| Breast | 1 | 2022 | 115 | 0.050 |
Why?
|
| Liver Cirrhosis | 1 | 2022 | 89 | 0.040 |
Why?
|
| Hepacivirus | 1 | 2022 | 125 | 0.040 |
Why?
|
| Early Detection of Cancer | 1 | 2020 | 149 | 0.040 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2018 | 30 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 154 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2018 | 160 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2018 | 257 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2018 | 126 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2012 | 16 | 0.020 |
Why?
|
| Optics and Photonics | 1 | 2012 | 12 | 0.020 |
Why?
|
| Fluorescence Polarization | 1 | 2012 | 31 | 0.020 |
Why?
|
| Methylene Blue | 1 | 2012 | 21 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 197 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2012 | 224 | 0.020 |
Why?
|
| Contrast Media | 1 | 2012 | 208 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2012 | 351 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2012 | 311 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2011 | 191 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2012 | 241 | 0.020 |
Why?
|
| Genotype | 1 | 2011 | 444 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2011 | 177 | 0.020 |
Why?
|
| Asthma | 1 | 2011 | 267 | 0.020 |
Why?
|
| Hypertension | 1 | 2011 | 385 | 0.020 |
Why?
|
| Neoplasms | 1 | 2012 | 863 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2011 | 3138 | 0.010 |
Why?
|